Patent · US Active

Biaryl kinase inhibitors

US10246469B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignees

Syngene International Limited · IN
Bristol-Myers Squibb Company · US

Inventors

Joanne J. Bronson · Madison, US
Ling Chen · Shanghai, CN
Jonathan L. Ditta · Meriden, US
Carolyn Diane Dzierba · Middletown, US
Prasada Rao Jalagam · Bengaluru, IN
Guanglin Luo · Newtown, US
John E. Macor · Guilford, US
Tarun Kumar Maishal · Bengaluru, IN
Susheel Jethanand Nara · Mumbai, IN
Ramkumar Rajamani · Wallingford, US
Ramesh Kumar Sistla · Bengaluru, IN
Soodamani Thangavel · Krishnagiri, IN

Key dates

Filing date	Sep 29, 2016
Grant date	Apr 2, 2019
Priority date	—
Expiry date	Sep 29, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to biaryl compounds of formula (I) which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds and their use for treating e.g. pain, Alzheimer's disease, Parkinson's disease and schizophrenia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.